ProfileGDS4132 / 231761_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 59% 57% 57% 45% 60% 60% 57% 64% 45% 48% 34% 33% 33% 41% 36% 31% 50% 39% 41% 34% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101164.17259
GSM201543Muscle PCOS pioglitazone 121148.06857
GSM201544Muscle PCOS pioglitazone 161158.79857
GSM201545Muscle PCOS pioglitazone 201125.95845
GSM201829Muscle PCOS pioglitazone 231178.34860
GSM201830Muscle PCOS pioglitazon 251173.0860
GSM201831Muscle PCOS pioglitazone 271160.06657
GSM201832Muscle PCOS pioglitazone 31175.81164
GSM201833Muscle PCOS pioglitazone 41111.29145
GSM201834Muscle PCOS pioglitazone 81125.09448
GSM201835Muscle PCOS after pioglitazone 10272.109734
GSM201836Muscle PCOS after pioglitazone 12273.003533
GSM201837Muscle PCOS after pioglitazone 16267.619833
GSM201838Muscle PCOS after pioglitazone 20295.75641
GSM201839Muscle PCOS after pioglitazone 23284.543536
GSM201840Muscle PCOS after pioglitazone 25272.518831
GSM201841Muscle PCOS after pioglitazone 272116.73550
GSM201842Muscle PCOS after pioglitazone 3282.434439
GSM201843Muscle PCOS after pioglitazone 42102.55341
GSM201844Muscle PCOS after pioglitazone 8279.691234